31 results
8-K
EX-10.1
EYPT
EyePoint Pharmaceuticals Inc
18 May 23
EyePoint Pharmaceuticals Announces Sale of YUTIQ® to Alimera Sciences, Inc. for $82.5 Million Cash Plus Royalties
7:06am
, the Product at the Facility and the 3PL Facility will be stored in a clean, secured and segregated area and otherwise in accordance with Applicable
10-KT
nv2h 2trdfu40
18 Mar 19
Annual report (with FYE transition)
5:30pm
8-K
EX-10.1
hcdon q04z8uddxh5j
19 Feb 19
EyePoint Pharmaceuticals Secures Up to $60 Million Debt Facility
4:00pm
10-K
9wsvn1
26 Sep 08
Annual report
12:00am